[1]
Mai, T.Q. et al. 2026. THE ROLE OF SEVERAL ¹⁸F-FDG PET/CT METABOLIC PARAMETERS IN PREDICTING TREATMENT RESPONSE FOLLOWING CONCURRENT CHEMORADIOTHERAPY IN PATIENTS WITH STAGE III ESOPHAGEAL CANCER. Journal of Military Pharmaco-medicine. 51, 7 (Jul. 2026), 25–34. DOI:https://doi.org/10.56535/jmpm.v51i7.1991.